Prostate Cancer Screening Practices Among High-Risk Patients

Prostate cancer is the second most common cancer in U.S. men, with higher incidence and mortality among African Americans and those with genetic or familial risk. Despite guidelines promoting early detection, prostate-specific antigen (PSA) screening in primary care remains inconsistent. We assessed PSA screening patterns and the association between risk factors and testing. A retrospective analysis was conducted on men aged ≥40 seen at primary care clinics from 2020 to 2022. Risk scores were created based on the number of prostate cancer risk factors. Univariate and multivariate analyses assessed associations between the risk scores, PSA screening, and cancer diagnosis. Of 176,326 patients, 31.4% underwent PSA testing, rising to 78.1% with a risk score of 4. The predictive model was significant (χ 2 = 19,527.021, df = 11, p

Family history · Guideline · Odds · Odds ratio · Prostate cancer · Prostate cancer screening · Prostate-specific antigen · Retrospective cohort study · Global Cancer Incidence and Screening · Health Promotion and Cardiovascular Prevention · Prostate Cancer Diagnosis and Treatment